Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 88%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,550
Total Claims
$1.4M
Drug Cost
755
Beneficiaries
$1,885
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+161%
Opioid rate vs peers
6.7% vs 2.6% avg
+76%
Cost per patient vs peers
$1,885 vs $1,068 avg
+46%
Brand preference vs peers
13.2% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
6.7%
Opioid Rate
776
Opioid Claims
$26K
Opioid Cost
1.7%
Long-Acting Rate
Brand vs Generic
Brand: 1,507 claims · $1.2M
Generic: 9,929 claims · $220K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 115 | $150K |
| Fluticasone/Umeclidin/Vilanter | 85 | $80K |
| Empagliflozin | 66 | $69K |
| Sitagliptin Phosphate | 63 | $66K |
| Apixaban | 48 | $60K |
| Insulin Glargine,hum.Rec.Anlog | 92 | $56K |
| Rivaroxaban | 41 | $51K |
| Budesonide/Formoterol Fumarate | 74 | $47K |
| Dapagliflozin Propanediol | 47 | $45K |
| Semaglutide | 41 | $41K |
| Insulin Aspart | 36 | $39K |
| Linaclotide | 39 | $38K |
| Insulin Lispro | 32 | $37K |
| Semaglutide | 14 | $32K |
| Mirabegron | 41 | $28K |
Prescribing Profile
Patient Profile
67
Avg Age
56%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About